Evaluation of hypericin-loaded solid lipid nanoparticles: Physicochemical properties, photostability and phototoxicity

References

• Zeisser-Labouebe M, Lange N, Gurny R, Delie F. Hypericin-loaded nanoparticles for the photodynamic treatment of ovarian cancer. Int J Pharm 2006;326:174–181.
   PubMed Web of Science ®Google Scholar
• Sharman WM, Allen CM, Van Lier JE. Photodynamic therapeutics: Basic principles and clinical applications. Drug Discov Today 1999;4:507–517.
   PubMed Web of Science ®Google Scholar
• Lange N. Controlled drug delivery in photodynamic therapy and fluorescence-based diagnosis of cancer. In: Mycek MA, Pogue BW, editors. Handbook of biomedical fluorescence. New York: Marcel Decker Inc.; 2003:563–635.
   Google Scholar
• Castano AP, Demidova TN, Hamblin MR. Mechanisms in photodynamic therapy: Part one. Photosensitizers, photochemistry and cellular localization. Photodiagn Photodyn Ther 2004;1:279–293.
   PubMed Web of Science ®Google Scholar
• Hooper CY, Guymer RH. New treatments in age-related macular degeneration. Clin Exp Ophthalm 2003;31:376–391.
   PubMed Web of Science ®Google Scholar
• Lavie G, Mazur Y, Lavie D, Meruelo D. The chemical and biological properties of hypericin: A compound with a broad-spectrum of biological activities. Med Res Rev 1995;15:111–119.
   PubMed Web of Science ®Google Scholar
• Agostinis P, Vantieghem A, MerlevedeW DeWitte, PAM. Hypericin in cancer treatment: More light on the way. Int J Biochem Cell Biol 2002;34:221–241.
   PubMed Web of Science ®Google Scholar
• Fox FE, Niu Z, Tobia A, Rook AH. Photoactivated hypericin is an anti-proliferative agent that induces a high rate of apoptotic death of normal, transformed, and malignant T lymphocytes: Implications for the treatment of cutaneous lymphoproliferative and inflammatory disorders. J Invest Dermatol 1998;111:327–332.
   PubMed Web of Science ®Google Scholar
• Shen L, Ji HF, Zhang HY. Anion of hypericin is crucial to understanding the photosensitive features of the pigment. Bioorg Med Chem Lett 2006;16:1414–1417.
   PubMed Web of Science ®Google Scholar
• Lavie G, Valentine F, Levin B, Mazur Y, Gallo G, Lavie D, Weiner D, Meruelo D. Studies of the mechanisms of action of the antiretroviral agents hypericin and pseudohypericin. Proc Nat Acad Sci USA 1989;86:5963–5967.
   PubMed Web of Science ®Google Scholar
• Hudson JB, Harris L, Towers GH. The importance of light in the anti-HIV effect of hypericin. Antiviral Res 1993;20:173–178.
   PubMed Web of Science ®Google Scholar
• Kraus GA, Zhang W, Fehr MJ, Petrich JW, Wannemuehler Y, Carpenter S. Research at the interface between chemistry and virology: Development of a molecular flashlight. Chem Rev 1996;96:523.
   PubMed Web of Science ®Google Scholar
• Duran N, Song PS. Hypericin and its photodynamic action. Photochem Photobiol 1986;43:677–680.
   PubMed Web of Science ®Google Scholar
• Diwu Z. Novel therapeutic and diagnostic applications of hypocrellins and hypericins. Photochem Photobiol 1995;61:529–539.
   PubMed Web of Science ®Google Scholar
• Huygens A, Kamuhabwa AR, De Witte PAM. Stability of different formulations and ion pairs of hypericin. Eur J Pharm Biopharm 2005;59:461–468.
   PubMed Web of Science ®Google Scholar
• Bonnett R, Martinez G. Photobleaching of sensitizers used in photodynamic therapy. Tetrahedron 2001;57:9513–9547.
   Web of Science ®Google Scholar
• Uzdensky AB, Iani V, Ma LW, Moan J. Photobleaching of hypericin bound to human serum albumin, cultured adenocarcinoma cells and nude mice skin. Photochem Photobiol 2002;76:320–328.
   PubMed Web of Science ®Google Scholar
• Liebes L, Mazur Y, Freeman D, Lavie D, Lavie G, Kudler N, Mendoza S, Levin B, Hochster H, Meruelo D. A method for the quantitation of hypericin, an antiviral agent, in biological fluids by high-performance liquid chromatography. Anal Biochem 1991;195:77–85.
   PubMed Web of Science ®Google Scholar
• Wirz A, Meier B, Sticher O. Stability of hypericin and pseudohypericin in extract solutions of Hypericum perforatum and in standard solutions. Pharm Ind 2001;63:410–415.
   Web of Science ®Google Scholar
• D’Hallewin MA, DeWitte PA, Waelkens E, Merlevede W, Baert L. Fluorescence detection of flat bladder carcinoma in situ after intravesical instillation of hypericin. J Urol 2000;164:349–351.
   PubMed Web of Science ®Google Scholar
• D’Hallewin MA, Kamuhabwa AR, Roskams T, DeWitte PAM, Baert L. Hypericin-based fluorescence diagnosis of bladder carcinoma. BJU Int 2002;89:760–763.
   PubMed Web of Science ®Google Scholar
• Yamazaki T, Ohta N, Yamazaki I, Song PS. Excited-state properties of hypericin: Electronic spectra and fluorescence decay kinetics. J Phys Chem 1993;97:7870–7875.
   Web of Science ®Google Scholar
• Weiner L, Mazur Y. EPR studies of hypericin: Photogeneration of free radicals and superoxide. J Chem Soc Perkin Trans 1992;2:1439–1442.
   Google Scholar
• Kamuhabwa AR, Roskams T, Baert L, DeWitte PA. Microscopic quantification of hypericin fluorescence in an orthotopic bladder tumor model after intravesical instillation. Int J Oncol 2003;22:933–937.
   PubMed Web of Science ®Google Scholar
• Burel L, Jardon P. Homo-association de l’hypéricine dans l’eau et consequences sur ses propriete’s photodynamiques. J Chim Phys 1996;93:300–316.
   Google Scholar
• Lin CW. Photodynamic therapy of malignant tumors – recent developments. Cancer Cells 1991;3:437–444.
   PubMed Web of Science ®Google Scholar
• Konan YN, Gurny R, Allemann E. State of the art in the delivery of photosensitizers for photodynamic therapy. J Photochem Photobiol B 2002;66:89–106.
   PubMed Web of Science ®Google Scholar
• Castano AP, Demidova TN, Hamblin MR. Mechanisms in photodynamic therapy: Part three. Photosensitizer pharmacokinetics, biodistribution, tumor localization and modes of tumor destruction. Photodiagn Photodyn Ther 2005;2:91–106.
   PubMed Web of Science ®Google Scholar
• Muller RH, Mader K, Gohla S. Solid lipid nanoparticles (SLN) for controlled drug delivery – a review of the state of the art. Eur J Pharm Biopharm 2000;50:161–177.
   PubMed Web of Science ®Google Scholar
• Abdelbary G, Fahmy RH. Diazepam-loaded solid lipid nanoparticles: Design and characterization. AAPS PharmSciTech 2009;10:211–219.
   PubMed Web of Science ®Google Scholar
• Guerrero DQ, Esquivel DT, Quintanar AG, Allemanna A, Doelker E. Adaptation and optimization of the emulsification-diffusion technique to prepare lipidic nanospheres. Eur J Pharm Sci 2005;26:211–218.
   PubMed Web of Science ®Google Scholar
• Mehnert W, Mader K. Solid lipid nanoparticles: Production, characterization and applications. Adv Drug Deliv Rev 2001;47:165–196.
   PubMed Web of Science ®Google Scholar
• Looi Y, Dong L, Jia A, Chang X, Xue H. Preparation and characterization of solid lipid nanoparticles loaded traditional Chinese medicine. Int J Biol Macromol 2006;38:296–299.
   PubMed Web of Science ®Google Scholar
• Shah KA, Date AA, Joshi MD, Patravale VB. Solid lipid nanoparticles (SLN) of tretinoin: Potential in topical delivery. Int J Pharm 2007;345:163–171.
   PubMed Web of Science ®Google Scholar
• Cavalli R, Morel S, Gasco MR, Chetoni P, Saettone MF. Preparation and evaluation in vitro of colloidal lipospheres containing pilocarpine as ion pair. Int J Pharm 1995;117:243–246.
   Web of Science ®Google Scholar
• Cavalli R, Caputo O, Carlotti M, Trotta M, Scarnecchia C, Gasco MR. Sterilization and freeze-drying of drug-free and drug-loaded solid lipid nanoparticles. Int J Pharm 1997;148:47–54.
   Web of Science ®Google Scholar
• Cavalli R, Marengo E, Rodriguez L, Gasco MR. Effects of some experimental factors on the production process of solid lipid nanoparticles. Eur J Pharm Biopharm 1996;42:110–115.
   Web of Science ®Google Scholar
• Gasco M. Solid lipid nanoparticles from microemulsions. Pharm Technol Eur 1997;9:52–58.
   Google Scholar
• Gasco MR. Method for producing solid lipid microspheres having a narrow size distribution. 1993 United State Patent US 5250236.
   Google Scholar
• Tiyaboonchai W, Tungpradit W, Plianbangchang P. Formulation and characterization of curcuminoids loaded solid lipid nanoparticles. Int J Pharm 2007;337:229–306.
   PubMedGoogle Scholar
• Gasco MR, Morel S, Carpigno R. Optimization of the incorporation of desoxycortisone acetate in lipospheres. Eur J Pharm Biopharm 1992;38:7–10.
   Web of Science ®Google Scholar
• Trotta M, Debernardi F, Caputo O. Preparation of solid lipid nanoparticles by a solvent emulsification-diffusion technique. Int J Pharm 2003;s57:153–160.
   Google Scholar
• Tadros TF. Emulsion stability. In: Becher P, editor. Encyclopedia of emulsion technology. vol. 1. New York: Marcel Dekker; 1983:129–285.
   Google Scholar
• Reddy LH, Murthy RSR. Etoposide-loaded nanoparticles made from glyceride lipids: Formulation, characterization, in vitro drug release, and stability evaluation. AAPS PharmSciTech 2005;6:E158–166
   PubMed Web of Science ®Google Scholar
• Porter CJH, Moghimi SM, Illum L, Davis SS. The polyoxyethylene/ polyoxypropylene block co-polymer poloxamer 407 selectively redirects intravenously injected microspheres to sinusoidal endothelial cells of rabbit bone marrow. FEBS Lett 1992;305:62–66.
   PubMed Web of Science ®Google Scholar
• Moghim SM, Hunter AC, Murray JC. Long-circulating and target-specific nanoparticles: Theory to practice. Pharmacol Rev 2001;53:283–318.
   PubMed Web of Science ®Google Scholar
• Hamdani J, Moes AJ, Amighi K. Physical and thermal characterization of Precirol and Compritol as lipophilic glycerides used for the preparation of controlled-release matrix pellets. Int J Pharm 2003;260:47–57.
   PubMed Web of Science ®Google Scholar
• Freitas C, Muller R. Correlation between long-term stability of solid lipid nanoparticles (SLN) and crystallinity of the lipid phase. Eur J Pharm Biopharm 1999;47:125–132.
   PubMed Web of Science ®Google Scholar
• Goppert T, Muller R. Protein adsorption patterns on poloxamer- and poloxamine-stabilized solid lipid nanoparticles (SLN). Eur J Pharm Biopharm 2005;60:361–372.
   PubMed Web of Science ®Google Scholar
• Hou D, Xie C, Huang K, Zhu C. The production and characteristics of solid lipid nanoparticles (SLNs). Biomaterials 2003;24:1781–1785.
   PubMed Web of Science ®Google Scholar
• Lv Q, Yu A, Xi Y, Li H, Song Z, Cui J, Cao J, Zhai G. Development and evaluation of penciclovir-loaded solid lipid nanoparticles for topical delivery. Int J Pharm 2009;372:191–198.
   PubMed Web of Science ®Google Scholar
• Kumar V, Chandrasekar D, Ramakrishna S, Kishan B, Rao YM, Diwan PV. Development and evaluation of nitrendipine loaded solid lipid nanoparticles: Influence of wax and glyceride lipids on plasma pharmacokinetics. Int J Pharm 2007;335:167–175.
   PubMed Web of Science ®Google Scholar
• Manjunath K, Venkateswarlu V. Pharmacokinetics, tissue distribution and bioavailability of clozapine solid lipid nanoparticles after intravenous and intraduodenal administration. J Control Release 2005;107:215–228.
   PubMed Web of Science ®Google Scholar
• Chirio D, Gallarate M, Trotta M, Carlotti ME, Gaudino EC, Cravotto G. Influence of α- and γ-cyclodextrin lipophilic derivatives on curcumin-loaded SLN. J Incl Phenom Macrocycl Chem 2009;65:391–402.
   Web of Science ®Google Scholar
• Ali SM, Olivo M. Bio-distribution and subcellular localization of hypericin and its role in PDT-induced apoptosis in cancer cells. Int J Oncol 2002;21:531–540.
   PubMed Web of Science ®Google Scholar
• Ritz R, Wein TH, Dietz K, Duffner F, Bornemann A, Roser F, Tatagiba M. Photodynamic therapy of malignant glioma with hypericin: Comprehensive in vitro study in human glioblastoma cell lines. Int J Oncol 2007;30:659–667.
   PubMed Web of Science ®Google Scholar
• Konan YN, Chevallier J, Gurny R, Allemann E. Encapsulation of p-THPP into nanoparticles: Cellular uptake, subcellular localization and effect of serum on photodynamic activity. Photochem Photobiol 2003;77:638–644.
   PubMed Web of Science ®Google Scholar